Obesity in CKD: A Promising Path Forward

Simple item page
dc.contributor.authorFriedman, Allon N.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-05-10T12:55:47Z
dc.date.available2024-05-10T12:55:47Z
dc.date.issued2022
dc.identifier.citationFriedman AN. Obesity in CKD: A Promising Path Forward. Clin J Am Soc Nephrol. 2022;17(12):1817-1819. doi:10.2215/CJN.09150822
dc.identifier.urihttps://hdl.handle.net/1805/40645
dc.language.isoen_US
dc.publisherWolters Kluwer
dc.relation.isversionof10.2215/CJN.09150822
dc.relation.journalClinical Journal of the American Society of Nephrology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectBariatric surgery
dc.subjectChronic kidney disease
dc.subjectGlucagon-like peptide-1 receptor agonist
dc.subjectGlucose-dependent insulinotropic polypeptide
dc.subjectObesity
dc.subjectWeight loss
dc.titleObesity in CKD: A Promising Path Forward
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718013/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Friedman2022Obesity-PP.pdf
Size:
224.77 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works